115 related articles for article (PubMed ID: 18390394)
1. Induction of hepatic glutathione S-transferase and UDP-glucuronosyltransferase activities by ketamine in rats.
Chan WH; Su HC; Hung MH; Sun WZ; Fan SZ; Hsiao PN; Ueng TH
Acta Anaesthesiol Taiwan; 2008 Mar; 46(1):2-7. PubMed ID: 18390394
[TBL] [Abstract][Full Text] [Related]
2. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
3. [Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase].
Yang J; Peng RX; Kong R; Yu JP
Yao Xue Xue Bao; 2001 May; 36(5):321-4. PubMed ID: 12584850
[TBL] [Abstract][Full Text] [Related]
4. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
[TBL] [Abstract][Full Text] [Related]
5. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen.
Nuwaysir EF; Daggett DA; Jordan VC; Pitot HC
Cancer Res; 1996 Aug; 56(16):3704-10. PubMed ID: 8706011
[TBL] [Abstract][Full Text] [Related]
6. Drug metabolizing enzyme induction by benzoquinolines, acridine, and quinacrine; tricyclic aromatic molecules containing a single heterocyclic nitrogen.
Le HT; Lamb JG; Franklin MR
J Biochem Toxicol; 1996; 11(6):297-303. PubMed ID: 9176741
[TBL] [Abstract][Full Text] [Related]
7. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
[TBL] [Abstract][Full Text] [Related]
8. [Disulfiram and butylhydroxyanisole induction of glutathione-S- and UDP glucuronosyltransferase activities in the liver and its role in preventing the toxic action of diethylnitrosamine in rats].
Kalinina EV; Spiridonova SM; Saprin AN; Berezov TT
Farmakol Toksikol; 1988; 51(5):89-92. PubMed ID: 3145215
[TBL] [Abstract][Full Text] [Related]
9. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
10. Concomitant induction of microsomal epoxide hydrolase and UDP-glucuronosyltransferase activities by dipyridine compounds.
Franklin MR; Moody DE
Drug Metab Dispos; 1992; 20(5):726-9. PubMed ID: 1358578
[TBL] [Abstract][Full Text] [Related]
11. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone.
Lamb JG; Franklin MR
Drug Metab Dispos; 2000 Sep; 28(9):1018-23. PubMed ID: 10950843
[TBL] [Abstract][Full Text] [Related]
12. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens.
van der Logt EM; Roelofs HM; Nagengast FM; Peters WH
Carcinogenesis; 2003 Oct; 24(10):1651-6. PubMed ID: 12869420
[TBL] [Abstract][Full Text] [Related]
13. Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein-malnourished rats.
Badary OA; AbdEl-Gawad HM; Taha RA; Ali AA; Hamada FM
J Biochem Mol Toxicol; 2003; 17(2):86-91. PubMed ID: 12717740
[TBL] [Abstract][Full Text] [Related]
14. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1.
Ishii Y; Takami A; Tsuruda K; Kurogi A; Yamada H; Oguri K
Drug Metab Dispos; 1997 Feb; 25(2):163-7. PubMed ID: 9029046
[TBL] [Abstract][Full Text] [Related]
15. Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.
Waxman DJ; Sundseth SS; Srivastava PK; Lapenson DP
Cancer Res; 1992 Oct; 52(20):5797-802. PubMed ID: 1394205
[TBL] [Abstract][Full Text] [Related]
16. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats.
Yao HT; Chang YW; Uramaru N; Watanabe Y; Kitamura S; Kuo YH; Lii CK; Yeh TK
J Ethnopharmacol; 2012 Jun; 142(1):121-8. PubMed ID: 22564357
[TBL] [Abstract][Full Text] [Related]
17. Changes in hepatic cytosolic glutathione S-transferase activity and expression of its class-P during prenatal and postnatal period in rats treated with aflatoxin B1.
Fatemi F; Allameh A; Dadkhah A; Forouzandeh M; Kazemnejad S; Sharifi R
Arch Toxicol; 2006 Sep; 80(9):572-9. PubMed ID: 16501953
[TBL] [Abstract][Full Text] [Related]
18. Effects of experimental diabetes on hepatic drug metabolism in rats: the activities of flavin-containing monooxygenase, the phase II conjugation reactions and glutathione related enzymes.
Toda A; Eyanagi R; Saito H; Soeda S; Shimeno H; Moriyama M; Shigematsu H
Res Commun Mol Pathol Pharmacol; 2005; 117-118():13-27. PubMed ID: 18426076
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.
Horn TL; Long L; Cwik MJ; Morrissey RL; Kapetanovic IM; McCormick DL
Chem Biol Interact; 2005 Apr; 152(2-3):79-99. PubMed ID: 15840382
[TBL] [Abstract][Full Text] [Related]
20. Effects of dietary anticarcinogens and nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases.
Van der Logt EM; Roelofs HM; van Lieshout EM; Nagengast FM; Peters WH
Anticancer Res; 2004; 24(2B):843-9. PubMed ID: 15161036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
